On Invalid Date, Xwell (NASDAQ: XWEL) reported Q2 2024 earnings per share (EPS) of -$0.48, up 64.96% year over year. Total Xwell earnings for the quarter were -$2.00 million. In the same quarter last year, Xwell's earnings per share (EPS) was -$1.37.
As of Q3 2024, Xwell's earnings has grown year over year. Xwell's earnings in the past year totalled -$21.01 million.
What was XWEL's revenue last quarter?
On Invalid Date, Xwell (NASDAQ: XWEL) reported Q2 2024 revenue of $9.28 million up 13.54% year over year. In the same quarter last year, Xwell's revenue was $8.18 million.
What was XWEL's revenue growth in the past year?
As of Q3 2024, Xwell's revenue has grown -1.95% year over year. This is 1.56 percentage points lower than the US Diagnostics & Research industry revenue growth rate of -0.38%. Xwell's revenue in the past year totalled $32.88 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.